Cargando…

Prolonged use of linezolid in bone and joint infections: a retrospective analysis of adverse effects

OBJECTIVES: Antibiotic treatment for bone and joint infections generally lasts for 6 weeks or longer. Linezolid may be a good option for treating bone and joint infections, but there is an increased risk of potential serious adverse drug events (ADEs) when used for more than 28 days. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veerman, Karin, Goosen, Jon, Spijkers, Karin, Jager, Nynke, Heesterbeek, Petra, Telgt, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631826/ https://www.ncbi.nlm.nih.gov/pubmed/37681570 http://dx.doi.org/10.1093/jac/dkad276

Ejemplares similares

Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study
por: Sawada, Masahiro, et al.
Publicado: (2019)

Assessment of antimicrobial mismatches in empirical treatment in early PJI after aseptic revision arthroplasty
por: Veerman, C M, et al.
Publicado: (2022)

Adverse reaction report and retrospective analysis of black hairy tongue caused by linezolid
por: Luo, Shaohua, et al.
Publicado: (2020)

Clinical use of linezolid in periprosthetic joint infections – a systematic review
por: Theil, Christoph, et al.
Publicado: (2020)

Clinical, Bacteriological, and Genetic Characterization of Bone and Joint Infections Involving Linezolid-Resistant Staphylococcus epidermidis: a Retrospective Multicenter Study in French Reference Centers
por: Coustillères, François, et al.
Publicado: (2023)

A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention
por: Morata, Laura, et al.
Publicado: (2014)

Debridement, Antibiotics and Implant Retention: A Systematic Review of Strategies for Treatment of Early Infections after Revision Total Knee Arthroplasty
por: Hulleman, Caspar W. J., et al.
Publicado: (2023)

Reversible Myelosuppresion With Prolonged Usage of Linezolid in Treatment of Methicillin-Resistant Staphylococcus aureus
por: Sharma, Sanjana, et al.
Publicado: (2020)

Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers
por: Thirot, Hélène, et al.
Publicado: (2021)

In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections
por: Littorin, C., et al.
Publicado: (2017)

Linezolid in the treatment of severe intraabdominal infection: A STROBE-compliant retrospective study
por: You, Deyuan, et al.
Publicado: (2022)

Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
por: Jaspard, Marie, et al.
Publicado: (2020)

Retrospective Study of Linezolid vs. Daptomycin for the Treatment of Vancomycin--resistant Enterococcal Bloodstream Infection
por: Rai, Rena, et al.
Publicado: (2017)

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
por: Cavalli, Zoé, et al.
Publicado: (2018)

Impact on the Gut Microbiota of Intensive and Prolonged Antimicrobial Therapy in Patients With Bone and Joint Infection
por: Levast, Benoît, et al.
Publicado: (2021)

Linezolid Resistance in Staphylococci
por: Stefani, Stefania, et al.
Publicado: (2010)

Linezolid-Associated Hypoglycemia
por: Johannesmeyer, Herman Joseph, et al.
Publicado: (2017)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

The Synergistic Activity of Rhamnolipid Combined with Linezolid against Linezolid-Resistant Enterococcus faecium
por: Chang, Qingru, et al.
Publicado: (2023)

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis
por: Imperial, Marjorie Z, et al.
Publicado: (2021)

Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2023)

Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
por: Valderrama, María-José, et al.
Publicado: (2020)

The Sinus Tract in Bone and Joint Infection: Minimally Invasive Salvation or Prolonged Suffering? A Multicenter Study
por: Klim, Sebastian Martin, et al.
Publicado: (2023)

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
por: Mayer, Karin, et al.
Publicado: (2022)

Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model
por: Thompson, John M., et al.
Publicado: (2017)

Animal experimental investigation on the efficacy of antibiotic therapy with linezolid, vancomycin, cotrimoxazole, and rifampin in treatment of periprosthetic knee joint infections by MRSA
por: Goetz, Julia, et al.
Publicado: (2022)

Two-Stage Revision Arthroplasty for Resistant Gram-Positive Periprosthetic Joint Infections Using an Oral Linezolid-Based Antibiotic Regime
por: Gründer, Lars, et al.
Publicado: (2023)

No correlation between minimal electrical charge at the tip of the stimulating catheter and the efficacy of the peripheral nerve block catheter for brachial plexus block: a prospective blinded cohort study
por: Schoenmakers, Karin PW, et al.
Publicado: (2014)

Treatment of prosthetic joint infections due to Propionibacterium: Similar results in 60 patients treated with and without rifampicin
por: Jacobs, Anouk M E, et al.
Publicado: (2016)

1250. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess
por: Al-Heeti, Omar, et al.
Publicado: (2021)

Linezolid-induced optic neuropathy
por: Karuppannasamy, Divya, et al.
Publicado: (2014)

Linezolide-induced hairy tongue
por: Braga-Simões, João, et al.
Publicado: (2016)

Linezolid-induced serotonin syndrome
por: Shouan, Anish, et al.
Publicado: (2020)

Mechanisms of Linezolid Resistance in Mycobacteria
por: Gan, Wei Chong, et al.
Publicado: (2023)

Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin
por: Reinecke, Pia, et al.
Publicado: (2023)

Effectiveness, safety, and cost of vancomycin and linezolid in Kuwait: A retrospective cohort study
por: Alghanem, Sarah S., et al.
Publicado: (2023)

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
por: Kainer, Marion A., et al.
Publicado: (2007)

Clinical update on linezolid in the treatment of Gram-positive bacterial infections
por: Ager, Sally, et al.
Publicado: (2012)

The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections
por: Fu, Jinjian, et al.
Publicado: (2013)

Linezolid for the treatment of postneurosurgical infection caused by methicillin-resistant Staphylococcus
por: Rebai, Lotfi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n94rar70svc6sf3bqf1307f636